Skip to content
Screener

Baxter International BAX Healthcare Systems & Technologies — Depreciation

Other segment segments

Medical Products & Therapies
$51M+4.1%
Pharmaceuticals
$16M0.0%

Similar metrics at other companies

INT
INTTEnvironmental Technologies — Depreciation
$67K+3.1%
INT
INTTProcess Technologies — Depreciation
$54K-12.9%
Vontier logo
VNTMobility Technologies — Depreciation
$6.7M-34.3%
Flotek Industries logo
FTKChemistry Technologies — Depreciation
$200K0.0%
nVent Electric plc logo
NVTSystems Protection — Depreciation
$9.1M+31.9%
Viasat logo
VSATDefense And Advanced Technologies — Depreciation
$12.52M+14.3%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Depreciation Expense1
Medical Products & Therapies$51$49
Healthcare Systems & Technologies2427
Pharmaceuticals1616
Total depreciation expense$91$92

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's healthcare systems & technologies — depreciation?
Baxter International (BAX) reported healthcare systems & technologies — depreciation of $24M in Q1 2026.
How has Baxter International's healthcare systems & technologies — depreciation changed year-over-year?
Baxter International's healthcare systems & technologies — depreciation decreased by 11.1% year-over-year, from $27M to $24M.
What is the long-term trend for Baxter International's healthcare systems & technologies — depreciation?
Over 4 years (2021 to 2025), Baxter International's healthcare systems & technologies — depreciation has grown at a 147.2% compound annual growth rate (CAGR), from $3M to $112M.
What does healthcare systems & technologies — depreciation mean?
The systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, over their useful lives. It reflects the wear and tear of the capital base required to support segment operations.

Ask your AI about Baxter International's healthcare systems & technologies — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude